Provivi, Inc.

About Provivi

Provivi, Inc. makes pheromone-based products that protect crops from insect pests. Pheromones are substances that attract insects, and the products use them to disrupt mating cycles. That lowers pest populations and cuts crop damage. A patented production method lowers the cost of making pheromones, so they can be used in high-acreage crops such as corn, rice and soy.

Provivi is based in Santa Monica, California, and was founded in 2013. Its cofounders include Frances Arnold, who won the 2018 Nobel Prize in Chemistry, along with Pedro Coelho and Peter Meinhold. Corey Huck became chief executive officer on September 1, 2024. James Demetriades, who founded Kairos Ventures, is executive chairman. Provivi has announced partnerships with Syngenta Biologicals, Godrej Agrovet, UPL Corp, Koppert and Andermatt Group.

Funding Rounds (SEC Form D)

First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.

What the SEC Filings Show

• Tulio Ribeiro first appears as a director on the Form D that Provivi filed on April 7, 2026. [16]
  Form D filings that name Tulio Ribeiro (4):

  • Provivi, director: Apr 7, 2026 · Sep 28, 2026 · Nov 3, 2026 (amended) · Nov 3, 2026
• Alan Boyce first appears as a director on the Form D that Provivi filed on April 7, 2026. [16]
  Form D filings that name Alan Boyce (4):

  • Provivi, director: Apr 7, 2026 · Sep 28, 2026 · Nov 3, 2026 (amended) · Nov 3, 2026
• Corey Huck first appears as a director on the Form D that Provivi filed on April 7, 2026. [16]
  Form D filings that name Corey Huck (4):

  • Provivi, CEO and director: Apr 7, 2026 · Sep 28, 2026 · Nov 3, 2026 (amended) · Nov 3, 2026
• Series C began taking money on June 20, 2019, about 3.8 months before the announcement. The Form D filed on October 8, 2019 shows $85.0 million sold of a $85.0 million offering, from 21 investors, or about $4.0 million each. [18]
• Frances Arnold was last listed as a director on the amended Form D that Provivi filed on October 8, 2019. [18]
  Form D filings that name Frances Arnold (10):

  • Provivi, director: Mar 12, 2015 · Mar 12, 2015 · Mar 12, 2015 (amended) · Jun 29, 2015 · Sep 3, 2015 (amended) · Jul 26, 2017 · Aug 7, 2017 (amended) · Sep 19, 2018 (amended) · Jul 5, 2019 · Oct 8, 2019 (amended)

Who Invested in Provivi

Scroll table to see all columns →

Announced amounts can differ from Form D figures: an announcement can combine several closings, and some money is raised without a Form D.

Why Investors Backed Provivi

Philip Erlanger of Pontifax AgTech saw regulatory and consumer pressure, coupled with resistant pests, as reasons growers needed alternatives to conventional crop chemicals. He viewed Provivi's pheromone technology as a direct response. [10]

Origin and Team

Provivi was founded in 2013 by Pedro Coelho, Peter Meinhold and Frances Arnold. Arnold won the 2018 Nobel Prize in Chemistry. [11]

Corey Huck previously led biologicals globally at Syngenta Group. His experience includes his family's Nebraska farm, early-stage agriculture technology companies and global agribusinesses. [4]

Product and Technology

Provivi's pheromones attract targeted insect species and disrupt mating without killing the insects. This lowers pest populations and crop losses while leaving beneficial insects unharmed. Its patented manufacturing method lowers costs enough for use in corn, rice and soy. [8][10]

By 2019, insect pheromones had more than 30 years of commercial use across about two million acres of permanent crops. Examples included apples, grapes and nuts. [10]

The second-generation FAW Eco-Dispenser is a pheromone-based product. [7]

Provivi's crop-monitoring app gives growers real-time information about ProviviFAW activity in their fields. It helps them make crop-management decisions. [5]

By August 2024, its products served corn growers in Mexico and rice growers in Indonesia. In Brazil, they served farmers growing soybeans, corn and cotton. The products were helping thousands of farmers worldwide. [3]

During its first full commercial year in Mexico, ProviviFAW ranked among the ten best-selling fall armyworm control products for corn. Growers saw less fall armyworm damage and used fewer insecticide applications. [5]

Use of Funds

• The Series B capital funded product and field development before commercial launch. [8]
• The Series B capital also funded further development, testing and commercialization of new pheromone products. [8]
• The Series C proceeds funded the launch of Provivi's pheromone products for farmers worldwide. [10]
• The Series C-2 proceeds funded expansion of Provivi-FAW in Mexico and preparations for more product launches in 2021. [12]
• The 2024 equity proceeds funded sustained business development, next-generation product development and work addressing growers' and environmental needs. [3]

Milestones

Scroll table to see all columns →

Market

Kairos Ventures framed Provivi's mission as safe pest control with limited environmental harm across agriculture, households and professional settings. It viewed the approach as protecting food supplies, limiting exposure to insecticide residues and remaining affordable and simple to use. [7]

James Demetriades, then managing partner of Kairos Ventures, took the view that the investment confirmed industry confidence in Provivi's technology. [8]

We wrote this summary from public statements by Provivi and its investors. It is not investment advice.

Leadership Team

Executive officers and directors listed on Provivi's Form D filed Nov 3, 2026.

Earlier filings also listed Ronald Olson (director, last listed Oct 2019), Peter Meinhold (executive officer, last listed Oct 2019), Pedro Coelho (chief executive officer and director, last listed Oct 2019), Paul Kuc (executive officer, last listed Oct 2019) and Frances Arnold (director, last listed Oct 2019).

Largest Form D Raises Filed the Same Day

Private companies with new Form D filings accepted by the SEC on Nov 3, 2026.

Sources

1. CompanyProvivi home page · linked above ↑
2. CompanyProvivi Series C announcement
3. CompanyProvivi 2024 equity financing announcement
4. CompanyProvivi CEO appointment and company update
5. CompanyProvivi Mexico commercial-sales update
6. InvestorBASF Venture Capital portfolio page
7. InvestorKairos Ventures Provivi portfolio page
8. InvestorKairos Ventures Series B announcement
9. SECProvivi Form D/A, filed 2026-11-03 · linked above ↑
10. CompanyProvivi Series C announcement
11. WireProvivi Series C release on PR Newswire
12. CompanyProvivi Series C-2 announcement
13. NewsAgFunderNews partnership coverage · linked above ↑
14. SECProvivi Form D, filed 2026-11-03 · linked above ↑
15. SECProvivi Form D, filed 2026-09-28
16. SECProvivi Form D, filed 2026-04-07 · linked above ↑
17. SECProvivi Form D, filed 2019-07-05
18. SECProvivi Form D/A, filed 2019-10-08 · linked above ↑
19. SECProvivi Form D, filed 2017-07-26
20. SECProvivi Form D/A, filed 2017-08-07
21. SECProvivi Form D/A, filed 2018-09-19 · linked above ↑
22. SECProvivi Form D, filed 2015-06-29
23. SECProvivi Form D/A, filed 2015-09-03 · linked above ↑
24. SECProvivi Form D, filed 2015-03-12
25. SECProvivi Form D/A, filed 2015-03-12 · linked above ↑
26. SECProvivi Form D, filed 2015-03-12 · linked above ↑
27. SECProvivi, Inc. filing history